AGENDA & FACULTY

New This Year: Expanded Q&A Time with Elite Faculty!

Continuing Education on the Unique Dermatologic Needs of Fitzpatrick III-VI Skin Types

SKIN OF COLOR UPDATE 2019 AGENDA & FACULTY

Topics include Hair Loss, Acne, Rosacea, Skin Care with Cosmeceuticals, PRP, Psoriasis, Scalp Psoriasis, Skin Cancer, Atopic Dermatitis, Hidradenitis Suppurativa, Nail and Fungal Disorders. Live Demonstrations with Fillers, Injectables, Peels, Lasers, Light and Energy-based Devices for Acne, Pigmentation, Skin Tightening, and Region-specific Facial Rejuvenation: Perioral, Periorbital, Volume Loss, etc.

Join the Waitlist

SOC Update 2019 Exclusive Agenda

SATURDAY September 7, 2019

TIME  WORKSHOPS FACULTY
7:00 AM Registration Desk Open
7:45 – 8:45 AM Breakfast Workshop – DUPIXENT® (dupilumab): Now Approved for an Expanded Indication
Supported by Regeneron 

Breakfast Service begins at 7:30 AM – Provided first come, first served
 Francisco A. Kerdel, MD

General Session – Hair & Scalp Disorders Mini Symposium with Panel Q&A

TIME PROGRAM FACULTY

9:00 AM

—

10:30 AM

 Welcome & Introduction Andrew Alexis, MD
Eliot Battle, MD

How to Approach Hair & Scalp Disorders in Skin of Color Patients

 Susan Taylor, MD

Treatment Strategies: What, How and When?

 Heather Woolery-Lloyd, MD

A Review of Alternative Treatment Therapies: PRP, Supplements, and Other Adjunctive Therapies

 Wendy Roberts, MD
Ask the Experts – Panel Q&A Susan Taylor, MD; Heather Woolery Lloyd, MD; Wendy Roberts, MD
 Live Demonstration   TBA
Live Demonstration

Refreshment Break Activities

TIME  WORKSHOPS FACULTY

10:30 AM
—
11:00 AM

 CE Working Group – Lasers and Device-Based Treatment of Scars


This session will explore the use of laser technology to treat different types of cutaneous scars.  Various laser scar revision techniques will be explored for the treatment of erythematous and pigmented scars, hypertrophic and atrophic scars, acne scars, surgical scars, burn scars, and complex traumatic scars. Following this session, the attendee should be able to categorize types of scars, choose the most appropriate therapies for various types of scars and identify treatment algorithm and laser techniques for treating scars.

 

Paul Friedman, MD

General Session – Hear it from the Experts: Acne, Rosacea, Psoriasis, & Keloids

TIME PROGRAM FACULTY

11:00 AM

—

12:45 PM

Acne: What’s New & What’s to Come

 Andrew Alexis, MD

Rosacea: Nuances in Clinical Presentation & Treatment – Case-Based Review

 Fran Cook-Bolden, MD

Psoriasis: Distinct Clinical Features and Treatment Options of Psoriasis Patients of Color

 Andrew Alexis, MD

Surgical Approaches for Keloids


Surgical approach for keloids sounds like an oxymoron since keloids are caused by trauma (surgery, deep injury to the skin that causes inflammation) in genetically predisposed individuals.  However, well orchestrated manipulations during and after surgery can help in the management of the patient with keloid formation tendency. The wound healing process and its alterations in the patient with keloid formation predisposition will be covered during this lecture along with surgical interventions including excisions with healing by second intention, application of immunomodulators as imiquimod, adding radiation therapy as an adjuvant, and using laser assistance. Dr. Perez will also cover physical manipulation alternatives.

 Maritza Perez, MD
Ask the Experts – Panel Q&A Fran Cook-Bolden, MD; Andrew Alexis, MD; Maritza Perez, MD

Live Chemical Peel Demonstration

 

Live Laser Demonstration

 Wendy Roberts, MD

 

Eliot Battle, MD (Moderator)

 Lunch Break Activities

TIME  WORKSHOPS FACULTY
12:45 – 1:45 PM

 

 Lunch Symposium: A Virtual Reality View – Evolving Standards of Care in Psoriasis: The Influence of Biologics on PASI Goals, Quality of Life and Special Populations

Crystal Aguh, MD

General Session – An Update on Cosmetic Dermatology: Safety and Efficacy of New Technologies and Procedures, Skin Lightening, and the Aging Process

TIME PROGRAM FACULTY

1:45 PM

—

3:30 PM

Skin Lightening: The Experts Weigh In – Panel Discussion with Q&A

Myriad products are marketed globally to lighten and brighten the skin. Such products are used to treat conditions such as melasma, post inflammatory hyperpigmentation, and dyschromias associated with sun damage and aging. Additionally, brightening agents are often used as key components of a daily cosmetic regimen. While hydroquinone use spans 60+ years, it remains a mainstay for lightening. However new agents/ topicals are showing improved efficacy.

The panel will discuss of an array of skin lightening ingredients available in mass market, prestige retail and cosmeceuticals, the gold standard versus lightening ingredients for the dermatologist and skin lightening ingredients. Additionally, there will be discussion of treatment regimens for PIH and melasma and quantitative assessment of treatment outcomes.

 

 Eliot Battle, MD; Pearl Grimes, MD; Cheryl Burgess, MD
Aging Process Across Ethnic Variations- Where We are and Where We Are Going


As America becomes more diversified, dermatologists need to know the variations in the aging process across ethnic differences to be able to help our patients in an individual fashion. Dr. Perez will delve into multi-decade, multiethnic, and multiple anatomic sites evaluation of the aging process as well as the signs of histological and genotypic and the differences found between ethnicities in the aging process.

 

 Maritza Perez, MD

Cosmetic Procedures in Patients of Color: What Every Dermatologist Should Know

With the demand for minimally invasive cosmetic procedures on the rise, it is becoming increasingly important for clinicians to be aware of specific and unique needs, in addition to, the possible complications that may occur in people of color. Dr. Burgess will cover cosmetic concerns in skin of color, anatomical considerations and techniques to optimize procedural predictability and safety and peri-procedural assessment and strategies for avoidance and management of complications.

 

 Cheryl Burgess, MD

Laser & Device-Based Aesthetic Treatments: What’s New & What Works

 Eliot Battle, MD

Pearls and Strategies for Preventing Laser Complications in Skin of Color Patients

  Eliot Battle, MD
 Live Laser Demonstration Eliot Battle, MD

Refreshment Break Activities

TIME  WORKSHOPS FACULTY

3:30 PM

—

4:00 PM  

 CE Working Group: Inflammatory Diseases

Andrew Alexis, MD

 

General Session

TIME PROGRAM FACULTY

4:00 PM

—

5:30 PM

Hidradenitis in Skin of Color 

Dr. Rosen will discuss the various aspects of hidradenitis as they apply to patients who belong to the skin of color demographic and the epidemiology of hidradenitis. He will also examine co-morbid states associated with hidradenitis in SOC, both on-label and innovative medical therapy for hidradenitis, and the advantages and disadvantages of surgical approaches to hidradenitis in SOC, particularly.

 

 Ted Rosen, MD

Pearls for the Diagnosis and Treatment of Atopic Dermatitis & Eczema in SOC Patients – Case-Based

   Andrew Alexis, MD
                                                                      Cosmeceuticals: The Most Effective Formulations for Fitzpatrick Skin Types IV-VI – Hands-On Expert Panel
Multiple studies document the delterious effects of ultraviolet exposure on long term skin health. Ultraviolet, visible, and infrared exposure cause erythema, free radicals and oxidative stress, mast cell mediated inflammation, angiogenesis, and hyperpigmentation. Recent studies have documented the role and mechanism of visible light and persistent hyperpigmentation. New data on photoprotection will be discussed along with new approaches for protection against visible light.		 Pearl Grimes, MD; Fran Cook-Bolden, MD;
Heather Woolery Lloyd, MD
Live Demonstration TBA

Evening Reception

TIME PROGRAM FACULTY
5:30 PM — 6:30 PM Shaping the Future of Aesthetics: An Interactive Reception with Galderma
Supported by Galderma Laboratories

SUNDAY September 8, 2019

TIME PROGRAM FACULTY
7:45 – 8:45 AM

 

 Breakfast Workshop – An Update on a Steroid-Free Topical Option for Mild-to-Moderate Atopic Dermatitis in Patients 2 Years and Older
Supported by PfizerBreakfast Service begins at 7:30 AM – Provided first come, first served		 Seemal Desai, MD
 

 

General Session
9:00 AM

—

11:30 AM

Diagnosis and Management of Vitiligo in Skin of Color Patients: Where Do We Stand?

Vitiligo is a common acquired disorder of the epidermis and hair follicles that manifests clinically as progressive depigmentation due to loss of functioning melanocytes. It affects 1% to 2% of the global population. Studies suggest an equal incidence in all racial-ethnic groups. However, because of the highly visible contrast between the constitutive skin color and the white patches, vitiligo can be particularly disfiguring in darker complexioned skin types. Given the disfiguring aspect of the disease, vitiligo can profoundly impact the quality of life in children and adults.

Multiple theories have been proffered for the pathogenesis of vitiligo. Multiple recent studies document the expanding role of immune mechanisms in the pathogenesis of vitiligo. In general, therapies for vitiligo address stabilization of the disease and repigmentation of affected sites. Stabilization agents include systemic corticosteroids, oral mini-pulse corticosteroid therapy, minocycline, and methotrexate. First-line therapies for repigmentation are calcineurin inhibitors, topical corticosteroids, and narrowband (NB)-UVB phototherapy. Vitiligo is characterized by depigmented patches occurring in a localize, generalized, or segmental distribution.

 

 Pearl Grimes, MD

Hyperpigmentation: Procedural & Topical Treatment Options – Pearls from the Experts

 Heather Woolery Lloyd, MD; Susan Taylor, MD

Melasma & PIH: An Update on Medical, Surgical, and Combination Treatment Strategies

Melasma is indeed a global disorder of major cosmetic significance. It negatively impacts the quality of life of patients. The pathogenesis of melasma is indeed complex. Multiple recent studies document the interplay of genetics, inflammation, oxidative stress, abnormal vascular responses, and sensitivity to hormones in the pathogenesis of this disorder. While there are no cures, multiple new therapies offer significant improvement. This forum will review the most recent global advances in the pathogenesis and treatment of melasma. Therapies to be reviewed include sunscreens, topical agents, and oral agents including tranexamic acid, chemical peels, micro needling, lasers, and light sources.

 

 Pearl Grimes, MD

Q&A with the Experts

 Pearl Grimes, MD;
Heather Woolery Lloyd, MD;
Susan Taylor, MD

Resurgence of (many) STDs

STDs are now resurgent in the US and around the globe. Recognition and timely therapy is critical to avoid long-term sequelae. During this lecture, Dr. Rosen will explore the current trend toward resurgent STDs, especially in SOC community and morphologic and laboratory clues to properly diagnose common and uncommon STDs. He will also delve into effective therapeutic interventions and bacterial prophylaxis to reduce risk of bacterial STDs.

 

 Ted Rosen, MD
Ethnicity Matters: Medical Dermatology Concerns Across Ethnic Groups- A Case-Based Review


Each panel expert will review specific case-based medical dermatology concerns across ethnic groups. Dr. Lim will discuss nummular dermatitis and vitiligo among East Asian patients and discuss the management and treatment options for each. Dr. Perez will explain the major dermatologic concerns in the Hispanic population including rashes and sequelas, pigment and more pigment, skin cancer surveillance and myths and taboos. She will address the dermatologic concerns in the Hispanic population including preventing inflammation, addressing pigment early, preventing skin cancer and educating the patient.

 

 Maritza Perez, MD; Henry Lim, MD; Wendy Roberts, MD

Complex Medical Dermatology Cases: What To Do About Them? – Expert Panel

During this panel discussion, expert faculty members will delve into complex medical dermatology cases and discuss treatment options and management for each. Dr. Rosen will review a case of fever and rash in detail and the additional clinical aspects of the underlying medical condition illustrated.

 

 Andrew Alexis, MD; Ted Rosen, MD

Live Demonstration

 TBA

Refreshment Break Activities

TIME  WORKSHOPS FACULTY

12:00 PM

—

12:30 PM

CE Working Group – Skin Cancer Detection in SOC

In patients with skin of color, Bowen’s, squamous cell carcinoma, basal cell carcinoma all tend to be pigmented; Palmar, plantar and mucosal melanoma are more common; Hypopigmented mycosis fungoides is common; and Cutaneous T cell lymphoma tends to have a more aggressive course. Dr. Lim will discuss each of these in detail and outline treatment options and management as well as steps to recognize the clinical manifestation of skin cancer in patients with SOC.

Henry Lim, MD

 

General Session

TIME PROGRAM FACULTY
12:30 PM

—

1:30 PM 

Generational Influences and Latino Skin Cancer Risk


In general, the Hispanic population is not aware of their propensity to skin cancer.  Surveys across different populations (young, adult, diverse communities) of hispanic patients has shown that the hispanic populations feels immune to the development of skin cancer.  Hence, the epidemic of melanoma induced death in this population. Dr. Perez will examine the incidence of skin cancer in the hispanic population, the mortality rate, and potential explanations for these findings 

 

 Maritza Perez, MD

Current Understanding and Novel Innovations in Photoprotection

Environmental impact of UV filters, and the FDA study on percutaneous absorption of UV filters have generated a lot of misunderstanding among all patients. During this session, the latest data on environmental impact of UV filters, the clinical relevance of detection of UV filters in plasma and the limitation of mineral (= inorganic) filters will be reviewed and discussed in detail.

 

Henry Lim, MD

Live Injection Demonstrations – Including Facial Assessment, Upper, Mid and Lower Face Injections

 Fran Cook Bolden, MD; Martiza Perez, MD
   

 

 Q&A with the Injectors Fran Cook Bolden, MD; Martiza Perez, MD

1:30 PM

—

2:30 PM 

 Lunch Symposium: Epiduo® Forte Gel in Moderate to Severe Acne Skin of Color Patients: EDEN Study
Supported by Galderma Laboratories		 Fran Cook-Bolden, MD

Join the Waitlist

2019 FACULTY

Conference Chairs

Andrew F. Alexis, MD, MPH

Andrew F. Alexis, MD, MPH

2019 Conference Chair

Read Bio

Eliot F. Battle, Jr., MD

Eliot F. Battle, Jr., MD

2019 Conference Chair

Read Bio

Faculty & Advisors

Cheryl Burgess, MD

Cheryl Burgess, MD

Faculty

Fran Cook-Bolden, MD

Fran Cook-Bolden, MD

Faculty

Paul Friedman, MD

Paul Friedman, MD

Faculty

Henry Lim, MD

Henry Lim, MD

Faculty

Maritza Perez, MD

Maritza Perez, MD

Faculty

Wendy Roberts, MD

Wendy Roberts, MD

Faculty

Ted Rosen, MD

Ted Rosen, MD

Faculty

Susan Taylor, MD

Susan Taylor, MD

Faculty

Heather Woolery Lloyd, MD

Heather Woolery Lloyd, MD

Faculty

Pearl Grimes, MD

Pearl Grimes, MD

Faculty